Skip to main content
Erschienen in: Japanese Journal of Radiology 10/2015

01.10.2015 | Original Article

Correlating Parkinson’s disease motor symptoms with three-dimensional [18F]FP-CIT PET

Erschienen in: Japanese Journal of Radiology | Ausgabe 10/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To investigate the correlation between the striatal three-dimensional location and the Unified Parkinson’s Disease Rating Scale (UPDRS) motor score in the context of idiopathic Parkinson’s disease (PD) through radiolabeled N-(3-fluoropropyl)-2β-carboxymethoxy-3β-(4-iodophenyl) nortropane positron emission tomography/computed tomography (FP-CIT PET/CT).

Materials and methods

In this cross-sectional study, we assessed the UPDRS motor score and performed FP-CIT PET/CT in patients with PD. Thirty-eight patients with idiopathic PD [average 70 years of age (range 49–86); male:female ratio 12:26] were enrolled. The correlation between FP-CIT PET/CT and the UPDRS III scores was investigated after the transformation of PET images by an alternative method using MATLAB.

Results

Left caudate nucleus uptake negatively correlated with UPDRS items 18, 20 (face), 22 (right arm and leg), 23, 24 (right side), 26 (right side), 27, 30, and 31, while right caudate nucleus uptake positively correlated with items 18, 22 (left arm), 26, and 29. Putamen uptake correlated with items 22 and 25. Left caudate nucleus uptake positively correlated with axial and akinetic-rigidity symptoms.

Conclusions

FP-CIT uptake in specific basal ganglia structures strongly correlated with the UPDRS III motor score. Among these, the left caudate nucleus exhibited the strongest relationship with axial and akinetic-rigidity PD symptoms.
Literatur
1.
Zurück zum Zitat Djaldetti R, Treves TA, Ziv I, Melamed E, et al. Use of a single [(123)I]-FP-CIT SPECT to predict the severity of clinical symptoms of Parkinson disease. Neurol Sci. 2009;30(4):301–5.CrossRefPubMed Djaldetti R, Treves TA, Ziv I, Melamed E, et al. Use of a single [(123)I]-FP-CIT SPECT to predict the severity of clinical symptoms of Parkinson disease. Neurol Sci. 2009;30(4):301–5.CrossRefPubMed
2.
Zurück zum Zitat Eggers C, Kahraman D, Fink GR, et al. Akinetic-rigid and tremor-dominant Parkinson’s disease patients show different patterns of FP-CIT single photon emission computed tomography. Mov Disord. 2011;26:416–23.CrossRefPubMed Eggers C, Kahraman D, Fink GR, et al. Akinetic-rigid and tremor-dominant Parkinson’s disease patients show different patterns of FP-CIT single photon emission computed tomography. Mov Disord. 2011;26:416–23.CrossRefPubMed
3.
Zurück zum Zitat Jellinger KA. Post mortem studies in Parkinson’s disease—is it possible to detect brain areas for specific symptoms? J Neural Transm Suppl. 1999;56:1–29.CrossRefPubMed Jellinger KA. Post mortem studies in Parkinson’s disease—is it possible to detect brain areas for specific symptoms? J Neural Transm Suppl. 1999;56:1–29.CrossRefPubMed
4.
Zurück zum Zitat Paulus W, Jellinger K. The neuropathologic basis of different clinical subgroups of Parkinson’s disease. J Neuropathol Exp Neurol. 1991;50:743–55.CrossRefPubMed Paulus W, Jellinger K. The neuropathologic basis of different clinical subgroups of Parkinson’s disease. J Neuropathol Exp Neurol. 1991;50:743–55.CrossRefPubMed
5.
Zurück zum Zitat Rajput AH, Voll A, Rajput ML, Robinson CA, et al. Course in Parkinson disease subtypes: a 39-year clinicopathologic study. Neurology. 2009;73:206–12.CrossRefPubMed Rajput AH, Voll A, Rajput ML, Robinson CA, et al. Course in Parkinson disease subtypes: a 39-year clinicopathologic study. Neurology. 2009;73:206–12.CrossRefPubMed
6.
Zurück zum Zitat Zaidel A, Arkadir D, Israel Z, et al. Akineto-rigid vs. tremor syndromes in Parkinsonism. Curr Opin Neurol. 2009;22:387–93.CrossRefPubMed Zaidel A, Arkadir D, Israel Z, et al. Akineto-rigid vs. tremor syndromes in Parkinsonism. Curr Opin Neurol. 2009;22:387–93.CrossRefPubMed
7.
Zurück zum Zitat Helmich RC, Hallett M, Deuschl G, Toni I, et al. Cerebral causes and consequences of parkinsonian resting tremor: a tale of two circuits? Brain. 2012;135:3206–26.PubMedCentralCrossRefPubMed Helmich RC, Hallett M, Deuschl G, Toni I, et al. Cerebral causes and consequences of parkinsonian resting tremor: a tale of two circuits? Brain. 2012;135:3206–26.PubMedCentralCrossRefPubMed
8.
Zurück zum Zitat Hilker R, Schweitzer K, Coburger S, et al. Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity. Arch Neurol. 2005;62:378–82.CrossRefPubMed Hilker R, Schweitzer K, Coburger S, et al. Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity. Arch Neurol. 2005;62:378–82.CrossRefPubMed
9.
Zurück zum Zitat Jankovic J, Kapadia AS. Functional decline in Parkinson disease. Arch Neurol. 2001;58:1611–5.CrossRefPubMed Jankovic J, Kapadia AS. Functional decline in Parkinson disease. Arch Neurol. 2001;58:1611–5.CrossRefPubMed
10.
Zurück zum Zitat Louis ED, Tang MX, Cote L, et al. Progression of parkinsonian signs in Parkinson disease. Arch Neurol. 1999;56:334–7.CrossRefPubMed Louis ED, Tang MX, Cote L, et al. Progression of parkinsonian signs in Parkinson disease. Arch Neurol. 1999;56:334–7.CrossRefPubMed
11.
Zurück zum Zitat Zetusky WJ, Jankovic J, Pirozzolo FJ. The heterogeneity of Parkinson’s disease: clinical and prognostic implications. Neurology. 1985;35:522–6.CrossRefPubMed Zetusky WJ, Jankovic J, Pirozzolo FJ. The heterogeneity of Parkinson’s disease: clinical and prognostic implications. Neurology. 1985;35:522–6.CrossRefPubMed
12.
Zurück zum Zitat Spiegel J, Hellwig D, Samnick S, et al. Striatal FP-CIT uptake differs in the subtypes of early Parkinson’s disease. J Neural Transm. 2007;114:331–5.CrossRefPubMed Spiegel J, Hellwig D, Samnick S, et al. Striatal FP-CIT uptake differs in the subtypes of early Parkinson’s disease. J Neural Transm. 2007;114:331–5.CrossRefPubMed
13.
Zurück zum Zitat Stoessl AJ. Radionuclide scanning to diagnose Parkinson disease: is it cost-effective? Nat Clin Pract Neurol. 2009;5:10–1.CrossRefPubMed Stoessl AJ. Radionuclide scanning to diagnose Parkinson disease: is it cost-effective? Nat Clin Pract Neurol. 2009;5:10–1.CrossRefPubMed
14.
Zurück zum Zitat de Lau LM, Breteler MM. Epidemiology of Parkinson’s disease. Lancet Neurol. 2006;5:525–35.CrossRefPubMed de Lau LM, Breteler MM. Epidemiology of Parkinson’s disease. Lancet Neurol. 2006;5:525–35.CrossRefPubMed
15.
Zurück zum Zitat Hubbuch M, Farmakis G, Schaefer A, et al. FP-CIT SPECT does not predict the progression of motor symptoms in Parkinson’s disease. Eur Neurol. 2011;65:187–92.CrossRefPubMed Hubbuch M, Farmakis G, Schaefer A, et al. FP-CIT SPECT does not predict the progression of motor symptoms in Parkinson’s disease. Eur Neurol. 2011;65:187–92.CrossRefPubMed
16.
Zurück zum Zitat Ottaviani S, Tinazzi M, Pasquin I, et al. Comparative analysis of visual and semi-quantitative assessment of striatal [123I] FP-CIT-SPET binding in Parkinson’s disease. Neurol Sci. 2006;27:397–401.CrossRefPubMed Ottaviani S, Tinazzi M, Pasquin I, et al. Comparative analysis of visual and semi-quantitative assessment of striatal [123I] FP-CIT-SPET binding in Parkinson’s disease. Neurol Sci. 2006;27:397–401.CrossRefPubMed
17.
Zurück zum Zitat Kahraman D, Eggers C, Schicha H, et al. Visual assessment of dopaminergic degeneration pattern in 123I-FP-CIT SPECT differentiates patients with atypical parkinsonian syndromes and idiopathic Parkinson’s disease. J Neurol. 2012;259:251–60.CrossRefPubMed Kahraman D, Eggers C, Schicha H, et al. Visual assessment of dopaminergic degeneration pattern in 123I-FP-CIT SPECT differentiates patients with atypical parkinsonian syndromes and idiopathic Parkinson’s disease. J Neurol. 2012;259:251–60.CrossRefPubMed
18.
Zurück zum Zitat O’Brien JT, Colloby S, Fenwick J, et al. Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies. Arch Neurol. 2004;61:919–25.CrossRefPubMed O’Brien JT, Colloby S, Fenwick J, et al. Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies. Arch Neurol. 2004;61:919–25.CrossRefPubMed
19.
Zurück zum Zitat Papathanasiou N, Rondogianni P, Chroni P, Datseris I, et al. Interobserver variability, and visual and quantitative parameters of 123I-FP-CIT SPECT (DaTSCAN) studies. Ann Nucl Med. 2012;26:234–40.CrossRefPubMed Papathanasiou N, Rondogianni P, Chroni P, Datseris I, et al. Interobserver variability, and visual and quantitative parameters of 123I-FP-CIT SPECT (DaTSCAN) studies. Ann Nucl Med. 2012;26:234–40.CrossRefPubMed
20.
Zurück zum Zitat Vingerhoets FJ, Schulzer M, Calne DB, et al. Which clinical sign of Parkinson’s disease best reflects the nigrostriatal lesion? Ann Neurol. 1997;41:58–64.CrossRefPubMed Vingerhoets FJ, Schulzer M, Calne DB, et al. Which clinical sign of Parkinson’s disease best reflects the nigrostriatal lesion? Ann Neurol. 1997;41:58–64.CrossRefPubMed
21.
Zurück zum Zitat Wang J, Zuo CT, Jiang YP, et al. 18F-FP-CIT PET imaging and SPM analysis of dopamine transporters in Parkinson’s disease in various Hoehn & Yahr stages. J Neurol. 2007;254:185–90.CrossRefPubMed Wang J, Zuo CT, Jiang YP, et al. 18F-FP-CIT PET imaging and SPM analysis of dopamine transporters in Parkinson’s disease in various Hoehn & Yahr stages. J Neurol. 2007;254:185–90.CrossRefPubMed
22.
Zurück zum Zitat Kazumata K, Dhawan V, Chaly T, et al. Dopamine transporter imaging with fluorine-18-FPCIT and PET. J Nucl Med. 1998;39:1521–30.PubMed Kazumata K, Dhawan V, Chaly T, et al. Dopamine transporter imaging with fluorine-18-FPCIT and PET. J Nucl Med. 1998;39:1521–30.PubMed
23.
Zurück zum Zitat Benamer HT, Patterson J, Wyper DJ, et al. Correlation of Parkinson’s disease severity and duration with 123I-FP-CIT SPECT striatal uptake. Mov Disord. 2000;15:692–8.CrossRefPubMed Benamer HT, Patterson J, Wyper DJ, et al. Correlation of Parkinson’s disease severity and duration with 123I-FP-CIT SPECT striatal uptake. Mov Disord. 2000;15:692–8.CrossRefPubMed
24.
Zurück zum Zitat Berti V, Pupi A, Ramat S, et al. Clinical correlation of the binding potential with 123I-FP-CIT in de novo idiopathic Parkinson’s disease patients. Eur J Nucl Med Mol Imaging. 2008;35:2220–6.CrossRefPubMed Berti V, Pupi A, Ramat S, et al. Clinical correlation of the binding potential with 123I-FP-CIT in de novo idiopathic Parkinson’s disease patients. Eur J Nucl Med Mol Imaging. 2008;35:2220–6.CrossRefPubMed
25.
Zurück zum Zitat Ma Y, Dhawan V, Mentis M, et al. Parametric mapping of [18F]FPCIT binding in early stage Parkinson’s disease: a PET study. Synapse. 2002;45:125–33.CrossRefPubMed Ma Y, Dhawan V, Mentis M, et al. Parametric mapping of [18F]FPCIT binding in early stage Parkinson’s disease: a PET study. Synapse. 2002;45:125–33.CrossRefPubMed
Metadaten
Titel
Correlating Parkinson’s disease motor symptoms with three-dimensional [18F]FP-CIT PET
Publikationsdatum
01.10.2015
Erschienen in
Japanese Journal of Radiology / Ausgabe 10/2015
Print ISSN: 1867-1071
Elektronische ISSN: 1867-108X
DOI
https://doi.org/10.1007/s11604-015-0427-0

Weitere Artikel der Ausgabe 10/2015

Japanese Journal of Radiology 10/2015 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.